Supplement

You have full text access to this OnlineOpen article

Guideline implementation for breast healthcare in low-income and middle-income countries†‡§

Overview of the Breast Health Global Initiative Global Summit 2007

  1. Benjamin O. Anderson MD1,2,¶,*,
  2. Cheng-Har Yip MD3,
  3. Robert A. Smith PhD4,
  4. Roman Shyyan MD5,
  5. Stephen F. Sener MD6,7,
  6. Alexandru Eniu MD8,
  7. Robert W. Carlson MD9,
  8. Edward Azavedo MD10,
  9. Joe Harford PhD11

Article first published online: 24 SEP 2008

DOI: 10.1002/cncr.23844

Issue

Cancer

Cancer

Supplement: Guidelines for International Breast Health and Cancer Control–Implementation

Volume 113, Issue Supplement 8, pages 2221–2243, 15 October 2008

Additional Information

How to Cite

Anderson, B. O., Yip, C.-H., Smith, R. A., Shyyan, R., Sener, S. F., Eniu, A., Carlson, R. W., Azavedo, E. and Harford, J. (2008), Guideline implementation for breast healthcare in low-income and middle-income countries. Cancer, 113: 2221–2243. doi: 10.1002/cncr.23844

Author Information

  1. 1

    Department of Surgery, University of Washington, Seattle, Washington

  2. 2

    Fred Hutchinson Cancer Research Center, Seattle, Washington

  3. 3

    University Malaya Medical Centre, Kuala Lumpur, Malaysia

  4. 4

    American Cancer Society, Atlanta, Georgia

  5. 5

    Lviv Cancer Center, Lviv, Ukraine

  6. 6

    Evanston Northwestern Healthcare, Evanston, Illinois

  7. 7

    Northwestern University Feinberg School of Medicine, Chicago, Illinois

  8. 8

    Cancer Institute I. Chiricuta, Cluj-Napoca, Romania

  9. 9

    Stanford University, Stanford, California

  10. 10

    Department of Radiology, Karolinska University Hospital, Stockholm, Sweden

  11. 11

    National Cancer Institute, Bethesda, Maryland

  1. Fax: (206) 543-8136;

*Department of Surgery, Box 356410, University of Washington, Seattle, WA 98195

  1. †

    The Breast Health Global Initiative (BHGI) gratefully acknowledges grants and conference support from the following organizations and agencies: Fred Hutchinson Cancer Research Center; Susan G. Komen For The Cure; American Society of Clinical Oncology; US National Cancer Institute, Office of International Affairs; American Cancer Society; Lance Armstrong Foundation; US Agency for Healthcare Research and Quality (*Grant 1 R13 HS017218-01); US Centers for Disease Control and Prevention, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion; American Society of Breast Disease; Oncology Nursing Society; US National Cancer Institute, Office of Women's Health; US National Institutes of Health, Office of Research on Women's Health. In addition, the BHGI received unrestricted educational grants from AstraZeneca, Bristol-Myers Squibb, Ethicon Endo-Surgery, F. Hoffmann-La Roche, GE Healthcare, Novartis Oncology, and Pfizer Oncology.

  2. ‡

    Complete financial disclosures are presented at the end of this article.

  3. §

    This article is a US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 3 OCT 2008
  2. Article first published online: 24 SEP 2008
  3. Manuscript Accepted: 24 JUN 2008
  4. Manuscript Received: 10 JUN 2008

Funded by

  • Fred Hutchinson Cancer Research Center
  • Susan G. Komen For The Cure
  • American Society of Clinical Oncology
  • US National Cancer Institute, Office of International Affairs
  • American Cancer Society
  • Lance Armstrong Foundation
  • US Agency for Healthcare Research and Quality. Grant Number: 1 R13 HS017218-01
  • US Centers for Disease Control and Prevention, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
  • American Society of Breast Disease
  • Oncology Nursing Society
  • US National Cancer Institute, Office of Women's Health
  • US National Institutes of Health, Office of Research on Women's Health
  • AstraZeneca
  • Bristol-Myers Squibb
  • Ethicon Endo-Surgery
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Novartis Oncology
  • Pfizer Oncology

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1896K)

REFERENCES

  • 1
    Anderson GF,Chu E. Expanding priorities-confronting chronic disease in countries with low income. N Engl J Med. 2007; 356: 209–211.
  • 2
    World Health Organization. 58th World Health Assembly Approved Resolution on Cancer Prevention and Control WHA58.22. Geneva, Switzerland: World Health Organization; 2005.
  • 3
    SloanFA,GelbandH, eds. Cancer Control Opportunities in Low- and Middle-Income Countries [summary]. Washington, DC: National Academies Press; 2007: 1–16.
  • 4
    Ferlay J,Bray F,Pisani P,Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. Lyon, France: IARC Press; 2004. Available at:http://www-dep.iarc.fr/. Accessed on August 26, 2008.
  • 5
    Parkin DM,Bray F,Ferlay J,Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74–108.
    Direct Link:
  • 6
    Parkin DM,Fernandez LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006; 12( 1 suppl): S70–S80.
    Direct Link:
  • 7
    Stewart B,Kleihues PE. World Cancer Report. Lyon, France: IARC Press; 2003.
  • 8
    IARC Working Group on the Evaluation of Cancer-Preventive Strategies. IARC Handbooks of Cancer Prevention. Vol. 7: Breast Cancer Screening. Lyon, France: Oxford University Press; 2002.
  • 9
    Porter P. “Westernizing” women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008; 358: 213–216.
  • 10
    Pal SK,Mittal B. Improving cancer care in India: prospects and challenges. Asian Pac J Cancer Prev. 2004; 5: 226–228.
  • 11
    Bray F,McCarron P,Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004; 6: 229–239.
  • 12
    Hisham AN,Yip CH. Spectrum of breast cancer in Malaysian women: overview. World J Surg. 2003; 27: 921–923.
  • 13
    Chopra R. The Indian scene. J Clin Oncol. 2001; 19( 18 suppl): 106S–111S.
  • 14
    Sant M,Allemani C,Berrino F, et al. Breast carcinoma survival in Europe and the United States. Cancer. 2004; 100: 715–722.
    Direct Link:
  • 15
    Greenlee RT,Murray T,Bolden S,Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50: 7–33.
    Direct Link:
  • 16
    Zotov V,Shyyan R. Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience. Breast J. 2003; 9( 2 suppl): S75–S80.
    Direct Link:
  • 17
    Carlson RW,Anderson BO,Burstein HJ, et al. Breast cancer. J Natl Compr Canc Netw. 2005; 3: 238–289.
  • 18
    Morrow M,Strom EA,Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002; 52: 277–300.
    Direct Link:
  • 19
    Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin. 2000; 50: 312–336.
  • 20
    Abrams JS. Adjuvant therapy for breast cancer—results from the USA consensus conference. Breast Cancer. 2001; 8: 298–304.
  • 21
    World Health Organization. Executive Summary of the National Cancer Control Programmes: Policies and Managerial Guidelines. Geneva, Switzerland: World Health Organization; 2002.
  • 22
    Anderson BO,Braun S,Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003; 9( 2 suppl): S42–S50.
    Direct Link:
  • 23
    Anderson BO,Shyyan R,Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006; 12( 1 suppl): S3–S15.
    Direct Link:
  • 24
    Winn RJ,Botnick WZ. The NCCN Guideline Program: a conceptual framework. Oncology (Williston Park). 1997; 11: 25–32.
  • 25
    Anderson BO,Braun S,Lim S,Smith RA,Taplin S,Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J. 2003; 9( 2 suppl): S51–S59.
    Direct Link:
  • 26
    Smith RA,Caleffi M,Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006; 12( 1 suppl): S16–S26.
    Direct Link:
  • 27
    Vargas HI,Anderson BO,Chopra R, et al. Diagnosis of breast cancer in countries with limited resources. Breast J. 2003; 9( 2 suppl): S60–S66.
    Direct Link:
  • 28
    Shyyan R,Masood S,Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006; 12( 1 suppl): S27–S37.
    Direct Link:
  • 29
    Carlson RW,Anderson BO,Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003; 9( 2 suppl): S67–S74.
    Direct Link:
  • 30
    Eniu A,Carlson RW,Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006; 12( 1 suppl): S38–S53.
    Direct Link:
  • 31
    Anderson BO,Yip CH,Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006; 12( 1 suppl): S54–S69.
    Direct Link:
  • 32
    Yip CH,Smith RA,Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer. 2008; 113( 8 suppl): 2244–2256.
    Direct Link:
  • 33
    Shyyan R,Sener SF,Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer. 2008; 113( 8 suppl): 2257–2268.
    Direct Link:
  • 34
    Eniu A,Carlson RW,El Saghir NS, et al. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer. 2008; 113( 8 suppl): 2269–2281.
    Direct Link:
  • 35
    Harford J,Azavedo E,Fischietto M. Guideline implementation for breast healthcare in low- and middle income countries: breast healthcare program resource allocation. Cancer. 2008; 113( 8 suppl): 2282–2296.
    Direct Link:
  • 36
    Bese NS,Munshi A,Budrukkar A, et al. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer. 2008; 113( 8 suppl): 2305–2314.
    Direct Link:
  • 37
    El Saghir NS,Eniu A,Carlson RW, et al. Locally advanced breast cancer: treatment guidelines and resource-driven implementation. Cancer. 2008; 113( 8 suppl): 2315–2324.
    Direct Link:
  • 38
    Masood S,Vass L,Ibarra JA, et al. Breast pathology guidelines implementation for countries of limited resources. Cancer. 2008; 113( 8 suppl): 2297–2304.
    Direct Link:
  • 39
    McTiernan A,Porter P,Potter JD. Breast cancer prevention in countries with diverse resources. Cancer. 2008; 113( 8 suppl): 2325–2330.
    Direct Link:
  • 40
    Kreps GL,Sivaram R. The central role of strategic health communication in enhancing breast cancer outcomes across the continuum of care in limited-resource countries. Cancer. 2008; 113( 8 suppl): 2331–2337.
    Direct Link:
  • 41
    Weiss NS. Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J. 2003; 9( 2 suppl): S86–S89.
    Direct Link:
  • 42
    Cazap E,Buzaid A,Garbino C, et al. Breast cancer in Latin America: results of the SLACOM/BCRF Expert Survey. Cancer. 2008; 113( 8 suppl): 2359–2365.
    Direct Link:
  • 43
    Pisani P,Parkin DM,Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006; 118: 149–154.
    Direct Link:
  • 44
    Duffy SW,Tabar L,Vitak B,Warwick J. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography? Breast J. 2006; 12( 1 suppl): S91–S95.
    Direct Link:
  • 45
    Nadkarni MS,Gupta PB,Parmar VV,Badwe RA. Breast conservation surgery without pre-operative mammography—a definite feasibility. Breast. 2006; 15: 595–600.
  • 46
    Abati A,Simsir A. Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices. Clin Lab Med. 2005; 25: 631–654.
  • 47
    Giuliano AE,Kirgan DM,Guenther JM,Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer [see comments]. Ann Surg. 1994; 220: 391–398; discussion 398-401.
  • 48
    Thorat MA,Rangole A,Nadkarni MS,Parmar V,Badwe RA. Revision surgery for breast cancer: single institution experience. Cancer. 2008; 113( 8 suppl): 2347–2352.
    Direct Link:
  • 49
    Nielsen HM,Overgaard M,Grau C,Jensen AR,Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiation therapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 B and C randomized studies. J Clin Oncol. 2006; 24: 2268–2275.
  • 50
    Ragaz J,Olivotto IA,Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005; 97: 116–126.
  • 51
    Bese NS,Kiel K,El-Gueddari Bel K,Campbell OB,Awuah B,Vikram B. Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J. 2006; 12( 1 suppl): S96–S102.
    Direct Link:
  • 52
    Hortobagyi GN,de la Garza Salazar J,Pritchard K, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005; 6: 391–401.
  • 53
    El Saghir NS,Khalil MK,Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007; 5: 225–233.
  • 54
    Goetz MP,Rae JM,Suman VJ, et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol. 2005; 23: 9312–9318.
  • 55
    DeMichele A,Aplenc R,Botbyl J, et al. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. J Clin Oncol. 2005; 23: 5552–5559.
  • 56
    Love RR. Defining a global research agenda for breast cancer. Cancer. 2008; 113( 8 suppl): 2366–2371.
    Direct Link:
  • 57
    Buchholz TA,Lehman CD,Harris JR, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol. 2008; 26: 791–797.
  • 58
    Cataliotti L,De Wolf C,Holland R, et al. Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer. 2007; 43: 660–675.
  • 59
    Barton MB,Frommer M,Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol. 2006; 7: 584–595.
  • 60
    Van Der Giessen PH,Alert J,Badri C, et al. Multinational assessment of some operational costs of teletherapy. Radiother Oncol. 2004; 71: 347–355.
  • 61
    Bese NS,Sut PA,Ober A. The effect of treatment interruptions in the postoperative irradiation of breast cancer. Oncology. 2005; 69: 214–223.
  • 62
    World Health Organization. Essential Medicines. WHO Model List, 2005. Available at: http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf. Accessed on August 26, 2008.
  • 63
    Bines J,Eniu A. Effective but cost prohibitive drugs in breast cancer treatment: a clinical review. Cancer. 2008; 113 ( 8 suppl): 2353–2358.
    Direct Link:
  • 64
    Ratain MJ,Cohen EE. The value meal: how to save $1700 per month or more on lapatinib. J Clin Oncol. 2007; 25: 3397–3398.
  • 65
    Pegram M,Hsu S,Lewis G, et al. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene. 1999; 18: 2241–2251.
  • 66
    World Health Organization. Access to Controlled Medications Programme: Briefing Note, 2007. Available at: http://www.who.int/medicines/areas/quality_safety/access_to_controlled_medications_brnote_english.pdf. Accessed January 22, 2008.
  • 67
    Webster R,Lacey J,Quine S. Palliative care: a public health priority in developing countries. J Public Health Policy. 2007; 28: 28–39.
  • 68
    Auerbach AD,Landefeld CS,Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med. 2007; 357: 608–613.
  • 69
    Weir HK,Thun MJ,Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003; 95: 1276–1299.
  • 70
    Clarke M. Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol. 2006; 17( 10 suppl): x59–x62.
  • 71
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43–66.
    Direct Link:
  • 72
    Bach PB,Schrag D,Brawley OW,Galaznik A,Yakren S,Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106–2113.
  • 73
    McCannon CJ,Berwick DM,Massoud MR. The science of large-scale change in global health. JAMA. 2007; 298: 1937–1939.
  • 74
    Committee on Quality of Health Cre in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Bethesda, MD: Institute of Medicine; 2001.
  • 75
    [No authors listed] IOM committee calls for complete revamping of health care system to achieve better quality. Qual Lett Healthc Lead. 2001; 13: 14–15.
  • 76
    Rubenstein LV,Pugh J. Strategies for promoting organizational and practice change by advancing implementation research. J Gen Intern Med. 2006; 21( 2 suppl): S58–S64.
  • 77
    Grimshaw J,Eccles M,Thomas R, et al. Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med. 2006; 21( 2 suppl): S14–S20.
  • 78
    Greenhalgh T,Robert G,Macfarlane F,Bate P,Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004; 82: 581–629.
    Direct Link:
  • 79
    Stalsberg H,Awuah B,Ibarra JA,Nsiah-Asare A. Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer. 2008; 113( 8 suppl): 2338–2346.
    Direct Link:
  • 80
    The NCCN Breast Cancer Screening and Diagnosis Guidelines. The Complete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM]. Version 1. Jenkintown, Pa: National Comprehensive Cancer Network; 2005.
  • 81
    Stavros AT,Thickman D,Rapp CL,Dennis MA,Parker SH,Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995; 196: 123–134.
  • 82
    Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol. 2003; 180: 1225–1228.
  • 83
    Fornage BD,Toubas O,Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer. 1987; 60: 765–771.
    Direct Link:
  • 84
    Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001; 221: 641–649.
  • 85
    Nomura Y,Kobayashi S,Takatani O,Sugano H,Matsumoto K,McGuire WL. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res. 1977; 37: 106–110.
  • 86
    Chow LW,Ho P. Hormonal receptor determination of 1052 Chinese breast cancers. J Surg Oncol. 2000; 75: 172–175.
    Direct Link:
  • 87
    Desai S,Ghosh TK,Chinoy R,Mohan A,Dinshaw KA. Telepathology at Tata Memorial Hospital, Mumbai and Barshi, a rural centre in Maharashtra. Natl Med J India. 2002; 15: 363–364.
View Full Article (HTML) Get PDF (1896K)